Fox Chase Cancer Center News

Philadelphia (September 28, 2018) – Fox Chase Cancer Center is pleased to announce that its scientists and clinicians earned several newly issued patents during fiscal years 2017 and 2018, the latter of which ended June 30, 2018.

PHILADELPHIA (September 25, 2018)— In addition to impacting cancer risk, mutations in the BRCA1 gene also have a role in determining whether a patient responds to certain types of therapies. In a new publication, Neil Johnson, PhD, found that cancers with different types of BRCA1 mutations have varying susceptibilities to biological pathways that induce resistance to PARP inhibitors, an emerging class of cancer drugs

PHILADELPHIA (August 23, 2018) – Alexander Kutikov, MD, FACS, chief, Division of Urology and Urologic Oncology at Fox Chase Cancer Center, has been named August’s Everyday Hero by the Pennsylvania Medical Society (PAMED). The award is designed to showcase talented physicians who probably don’t view themselves as heroes, but to patients and colleagues they are.

PHILADELPHIA (September 21, 2018)— On September 21, Vice President Joe Biden and Dr. Jill Biden are hosting the National Biden Cancer Summit in Washington, D.C., to drive the urgency of now by promoting new solutions, bringing together problem solvers, and telling stories that epitomize what it means to be cancer FIERCE. The Life Raft Group will announce a new initiative to strengthen and advance research for effective treatments of a rare subset of Gastrointestinal Stromal Tumor (GIST) patients who have been unresponsive to the current standard treatments. 

PHILADELPHIA (September 17, 2018)— On September 20, 2018, J. Robert Beck, MD, Senior Vice President and Deputy Cancer Center Director at Fox Chase Cancer Center, will receive the West Oak Lane Charter School Community Champion Award, in recognition of Dr. Beck’s support of WOLCS’s STEM program.

PHILADELPHIA (September 11, 2018) – This one-mile walk around Fox Chase Cancer Center’s main campus is a fundraiser for pancreatic cancer research and the postdoctoral research program. Participants will enjoy a variety of vendors, professional pet photos, animal rescue organizations, entertainment, refreshments, contests, and prizes.

PHILADELPHIA (September 10, 2018)— Chemoprevention was effective in reducing the incidence of colorectal cancer in a new study, but the therapies worked differently depending on whether mice presented with or without benign tumors at the time the intervention started. 

PHILADELPHIA (September 6, 2018) – Researchers at Fox Chase Cancer Center have demonstrated for the first time how two diet-dependent signaling pathways fit together to control the health and lifespan of stem cells. Their work shows that manipulating the balance between these pathways can influence how long stem cells live and how long they can reproduce.